Gene · 2348
Papers3,253
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,253
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Breakthrough of solid tumor treatment: CAR-NK immunotherapy. | Cell Death Discov | 2024 | 38245520 | PubTator, text mining | PubMed |
| Metastatic Ovarian Serous Adenocarcinoma Clinically Presenting as Inflammatory Breast Cancer. | Case Rep Oncol Med | 2024 | 38239272 | PubTator, text mining | PubMed |
| A self-assembled three-dimensional hierarchical nanoflower: an efficient enzyme-mimetic material for cancer cell detection that improves ROS generation for therapy. | Nanoscale Adv | 2024 | 38235072 | PubTator, text mining | PubMed |
| Vitamin D and Its Receptors in Cervical Cancer. | J Cancer | 2024 | 38230221 | PubTator, text mining | PubMed |
| Virus-like particle vaccine displaying an external, membrane adjacent MUC16 epitope elicits ovarian cancer-reactive antibodies. | J Ovarian Res | 2024 | 38225646 | PubTator, text mining | PubMed |
| Advancing intraoperative tumour detection and molecular-guided precision surgery, FDA's approval of pafolacianine injection: an editorial. | Ann Med Surg (Lond) | 2024 | 38222777 | PubTator, text mining | PubMed |
| Folate receptor overexpression induces toxicity in a diet-dependent manner in C. elegans. | Sci Rep | 2024 | 38212621 | PubTator, text mining | PubMed |
| Predictive and prognostic biomarkers in female genital tract tumours: an update highlighting their clinical relevance and practical issues. | Pathology | 2024 | 38212229 | PubTator, text mining | PubMed |
| Primary T-cell-based delivery platform for in vivo synthesis of engineered proteins. | Bioeng Transl Med | 2024 | 38193126 | PubTator, text mining | PubMed |
| Imaging Evaluation of Peritoneal Metastasis: Current and Promising Techniques. | Korean J Radiol | 2024 | 38184772 | PubTator, text mining | PubMed |
| Antibodies to watch in 2024. | MAbs | 2024 | 38178784 | PubTator, text mining | PubMed |
| The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors. | J Hematol Oncol | 2024 | 38178200 | PubTator, text mining | PubMed |
| Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay. | Clin Proteomics | 2024 | 38172678 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates in Gynecologic Cancers. | Curr Treat Options Oncol | 2024 | 38172449 | PubTator, text mining | PubMed |
| microRNA-622 upregulates cell cycle process by targeting FOLR2 to promote CRC proliferation. | BMC Cancer | 2024 | 38166756 | PubTator, text mining | PubMed |
| Biology-driven therapy advances in high-grade serous ovarian cancer. | J Clin Invest | 2024 | 38165032 | PubTator, text mining | PubMed |
| Development of antibody-drug conjugates in cancer: Overview and prospects. | Cancer Commun (Lond) | 2024 | 38159059 | PubTator, text mining | PubMed |
| Low-dose daily folic acid (400 μg) supplementation does not affect regulation of folate transporters found present throughout the terminal ileum and colon of humans: a randomized clinical trial. | Am J Clin Nutr | 2024 | 38157986 | PubTator, text mining | PubMed |
| Efficacy and safety of mirvetuximab soravtansine in recurrent ovarian cancer with FRa positive expression: A systematic review and meta-analysis. | Crit Rev Oncol Hematol | 2024 | 38122916 | PubTator, text mining | PubMed |
| Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer. | Int J Gynecol Cancer | 2024 | 38101816 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2348/papers?page=20